NKGen Biotech
(NASDAQ) NKGN
NKGen Biotech Financials at a Glance
Market Cap
N/A
Revenue (TTM)
$652.00K
Net Income (TTM)
$23.55M
EPS (TTM)
N/A
P/E Ratio
N/A
Dividend
N/A
Beta (Volatility)
N/A
Dividend
N/A
Beta (Volatility)
N/A
Price
N/A
Volume
N/A
Open
N/A
Price
N/A
Volume
N/A
Open
N/A
Previous Close
N/A
Daily Range
N/A
52-Week Range
N/A
Dividend
N/A
Beta (Volatility)
N/A
Price
N/A
Volume
N/A
Open
N/A
Previous Close
N/A
Daily Range
N/A
52-Week Range
N/A
NKGN News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout NKGen Biotech
Industry
Biotechnology
Sector
Health CareEmployees
26
CEO
Paul Y. Song, MD, PhD
Website
www.nkgenbiotech.comHeadquarters
Santa Ana, CA 92705, US
NKGN Financials
Key Financial Metrics (TTM)
Gross Margin
50%
Operating Margin
-15%
Net Income Margin
-22%
Return on Equity
56%
Return on Capital
35%
Return on Assets
-89%
Earnings Yield
N/A
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
N/A
Shares Outstanding
N/A
Volume
N/A
Short Interest
N/A
Avg. Volume
N/A
Financials (TTM)
Gross Profit
$0.00
Operating Income
$26.97M
EBITDA
$26.97M
Operating Cash Flow
$20.88M
Capital Expenditure
$0.00
Free Cash Flow
$20.88M
Cash & ST Invst.
$0.00
Total Debt
$0.00
NKGen Biotech Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$0.00
N/A
Gross Profit
$0.00
N/A
Gross Margin
0.00%
N/A
Market Cap
N/A
N/A
Market Cap/Employee
N/A
N/A
Employees
63
N/A
Net Income
$15.35M
+385.2%
EBITDA
$16.24M
+507.3%
Quarterly Fundamentals
Net Cash
$38.19M
-72.2%
Accounts Receivable
$23.00K
-11.5%
Inventory
$0.00
N/A
Long Term Debt
$11.28M
+7.5%
Short Term Debt
$26.91M
+129.6%
Return on Assets
-88.78%
N/A
Return on Invested Capital
34.82%
N/A
Free Cash Flow
$2.85M
+29.3%
Operating Cash Flow
$2.80M
+30.6%